Imagion Biosystems Share Price and Company Fundamentals
Last traded: Today at 6:10 AM
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to find and detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis. The company was incorporated in 2016 and is based in San Diego, California.
|Primary activities||Research and development of medical diagnostics|
|Industry / Sector||Diagnostics & Research / Healthcare|
|Mailing address||10355 Science Center Drive Suite 210 San Diego CA 92121 United States|
|Phone / Fax||855 564 5264 /|
|Share registry||BOARDROOM PTY LIMITED|
Imagion Biosystems does not pay dividends.
As of May 2021, following are the company executives and directors listed on Imagion Biosystems.
|Mr. Robert Romeo Proulx||Exec. Chairman, Pres & CEO||62||436.35k|
|Mr. Geoff Hollis||CFO & Company Sec.||306.32k|
|Dr. Marie Zhang||Vice-Pres of Research & Pre- Clinical Dev|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Imagion Biosystems is 95.81M and its enterprise value is 82.02M. The enterprise value to revenue ratio of IBX is 30.41.
The IBX's stocks Beta value is 3.42 making it 242% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Imagion Biosystems (IBX)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Imagion Biosystems (ASX:IBX) Frequently Asked Questions
1. What is Imagion Biosystems's Stock Symbol?
Imagion Biosystems trades on ASX under the ticker symbol "IBX".
2. What is Imagion Biosystems's stock price today?
One share of IBX stock can currently be purchased for approximately $0.092.
3. How can I contact Imagion Biosystems?
Imagion Biosystems's mailing address is 10355 Science Center Drive Suite 210 San Diego CA 92121 United States. The company can be reached via phone at 855 564 5264.
4. What is Imagion Biosystems's official website?
The official website of Imagion Biosystems is http://imagionbiosystems.com.
5. Which share registry manages Imagion Biosystems's stock?
Imagion Biosystems's stock is managed by BOARDROOM PTY LIMITED.